Physician

Hossein Amirani, MD

According to 2025 Medicare claims, Hossein Amirani, MD (NPI: 1164493201) practices cardiology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is CARDIOVASCULAR CARE, P.A. (NPI: 1902877038; TIN: 203461566) and primary practice location at 67114-9056. Amirani is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Amirani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,888 traditional Medicare patients, billed 21,810 HCPCS/CPT codes, and received $908,211 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 24,968 prescription claims across 2,514 beneficiaries totaling $5,059,753 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 26 claims. Open Payments data shows 87 records totaling $5,622. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $576,977 to $5,059,753. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $19,852 and ending at $20,451.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,712	30,919	$1,226,189
2016	2,707	31,919	$1,192,101
2017	2,944	40,911	$1,292,343
2018	3,150	44,331	$1,333,486
2019	3,274	46,085	$1,461,146
2020	3,424	43,658	$1,378,665
2021	3,469	47,623	$1,490,927
2022	3,378	39,566	$1,478,629
2023	3,357	37,698	$1,350,259
2024	2,888	21,810	$908,211

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,438	15,225	$576,977
2016	1,546	17,354	$838,968
2017	1,746	19,064	$1,226,429
2018	1,914	19,892	$1,756,773
2019	2,103	20,321	$2,445,217
2020	2,185	21,472	$2,908,865
2021	2,234	21,179	$3,182,576
2022	2,218	21,053	$3,732,411
2023	2,275	22,222	$4,595,834
2024	2,514	24,968	$5,059,753

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	15	$30,011
2017	N/R	11	$21,335
2018	N/R	26	$48,580
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	652	653	$264
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,506	1,543	$81
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	928	1,274	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,456	1,781	$51
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,087	1,277	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	2,455	100,385	$1,932,455
Xarelto	Rivaroxaban	1,261	66,002	$1,206,221
Entresto	Sacubitril/Valsartan	462	19,891	$433,387
Farxiga	Dapagliflozin Propanediol	444	20,986	$388,298
Jardiance	Empagliflozin	350	13,850	$263,459

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$5,622	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hossein Amirani, MD?

Tedicare shows public-source Medicare data for Hossein Amirani, MD (NPI 1164493201), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hossein Amirani, MD have ACO affiliation data?

Hossein Amirani, MD is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Hossein Amirani, MD?

Hossein Amirani, MD is linked to CARDIOVASCULAR CARE, P.A. (billing NPI 1902877038) in the available physician profile data.

Does Hossein Amirani, MD have Open Payments data?

Hossein Amirani, MD has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.